Log in

688319 Chengdu Olymvax Biopharmaceuticals Inc. SSE · China

Chengdu Olymvax Biopharmaceuticals (688319) news

Chengdu Olymvax Biopharmaceuticals Inc. is a public biotech or pharmaceutical company listed on SSE under the ticker 688319, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Chengdu Olymvax Biopharmaceuticals news

We have not published a story on Chengdu Olymvax Biopharmaceuticals yet. When there is news, it will appear here.

Questions about Chengdu Olymvax Biopharmaceuticals

What is the ticker symbol of Chengdu Olymvax Biopharmaceuticals?

Chengdu Olymvax Biopharmaceuticals Inc. trades under the ticker 688319 on SSE.

Where is Chengdu Olymvax Biopharmaceuticals listed?

Chengdu Olymvax Biopharmaceuticals Inc. is listed on SSE.

Which country or territory is Chengdu Olymvax Biopharmaceuticals listed under?

Our directory records Chengdu Olymvax Biopharmaceuticals Inc. under China.

What does Chengdu Olymvax Biopharmaceuticals do?

Our directory classifies Chengdu Olymvax Biopharmaceuticals Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Chengdu Olymvax Biopharmaceuticals?

The ISIN recorded for Chengdu Olymvax Biopharmaceuticals Inc. is CNE1000051H8.

Does aibio.space cover Chengdu Olymvax Biopharmaceuticals?

aibio.space lists Chengdu Olymvax Biopharmaceuticals Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Chengdu Olymvax Biopharmaceuticals?

Companies in our directory listed in the same country and business area as Chengdu Olymvax Biopharmaceuticals: XtalPi Holdings, PegBio Co., EVOPOINT BIOSCIENCES CO LTD, IMPACT Therapeutics, Shanghai ZJ Bio-Tech Co., Shanghai Rightongene Biotechnology Co..

Investor discussion: Chengdu Olymvax Biopharmaceuticals

Members talk about Chengdu Olymvax Biopharmaceuticals (688319). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open SSE:688319 on TradingView.

Listing details

Chengdu Olymvax Biopharmaceuticals Inc. is a public biotech or pharmaceutical company listed on SSE under the ticker 688319, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Chengdu Olymvax Biopharmaceuticals Inc.
Ticker
688319
Listing
SSE
Country or territory
China
Business scope
Biotechnology
ISIN
CNE1000051H8
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.